Last week, we covered the controversial approval of the first Alzheimer’s drug in 20 years. Last year, the FDA advisory committee determined that there wasn’t enough support that the treatment is effective. According to a CNN Health article, one member of the committee has resigned in protest of the recent approval of Biogen’s experimental drug that costs $56k/year.
Alzheimer Drug Approval Leads FDA Advisor to Resign
A Mayo Clinic neurologist resigned in protest of the FDA’s questionable approval of aducanumab.
Jun 15, 2021
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now